Cargando…

Influencing factors on serum 25-hydroxyvitamin D(3) levels in Japanese chronic hepatitis C patients

BACKGROUND: Serum 25-hydroxyvitamin D(3) levels are generally lower in chronic hepatitis C patients than in healthy individuals. The purpose of this study is to clarify the factors which affect serum 25-hydroxyvitamin D(3) levels using data obtained from Japanese chronic hepatitis C patients. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Yoshizawa, Kai, Abe, Hiroshi, Asano, Toru, Ohkubo, Yusuke, Araki, Masahiro, Ikegami, Tadashi, Kondo, Chisa, Itokawa, Norio, Nakagawa, Ai, Arai, Taeang, Matsushita, Yoko, Nakatsuka, Katsuhisa, Furihata, Tomomi, Chuganji, Yoshimichi, Matsuzaki, Yasushi, Aizawa, Yoshio, Iwakiri, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543479/
https://www.ncbi.nlm.nih.gov/pubmed/26286329
http://dx.doi.org/10.1186/s12879-015-1020-y
Descripción
Sumario:BACKGROUND: Serum 25-hydroxyvitamin D(3) levels are generally lower in chronic hepatitis C patients than in healthy individuals. The purpose of this study is to clarify the factors which affect serum 25-hydroxyvitamin D(3) levels using data obtained from Japanese chronic hepatitis C patients. METHODS: The subjects were 619 chronic hepatitis C patients. Serum 25-hydroxyvitamin D(3) levels were measured by using double-antibody radioimmunoassay between April 2009 and August 2014. Serum 25-hydroxyvitamin D(3) levels of 20 ng/mL or less were classified as vitamin D deficiency, and those with serum 25-hydroxyvitamin D(3) levels of 30 ng/mL or more as vitamin D sufficiency. The relationship between patient-related factors and serum 25-hydroxyvitamin D(3) levels was analyzed. RESULTS: The cohort consisted of 305 females and 314 males, aged between 18 and 89 years (median, 63 years). The median serum 25-hydroxyvitamin D(3) level was 21 ng/mL (range, 6–61 ng/mL). On the other hand, the median serum 25-hydroxyvitamin D(3) level in the healthy subjects was 25 ng/mL (range, 7–52), being significantly higher than that those in 80 chronic hepatitis C patients matched for age, gender, and season (p = 1.16 × 10(−8)). In multivariate analysis, independent contributors to serum 25-hydroxyvitamin D(3) deficiency were as follows: female gender (p = 2.03 × 10(−4), odds ratio = 2.290, 95 % confidence interval = 1.479–3.545), older age (p = 4.30 × 10(−4), odds ratio = 1.038, 95 % confidence interval = 1.017–1.060), cold season (p = 0.015, odds ratio = 1.586, 95 % confidence interval = 1.095–2.297), and low hemoglobin level (p = 0.037, odds ratio = 1.165, 95 % confidence interval = 1.009–1.345). By contrast, independent contributors to serum 25-hydroxyvitamin D(3) sufficiency were male gender (p = 0.001, odds ratio = 3.400, 95 % confidence interval = 1.635–7.069), warm season (p = 0.014, odds ratio = 1.765, 95 % confidence interval = 1.117–2.789) and serum albumin (p = 0.016, OR = 2.247, 95 % CI = 1.163–4.342). CONCLUSIONS: Serum 25-hydroxyvitamin D(3) levels in chronic hepatitis C Japanese patients were influenced by gender, age, hemoglobin level, albumin and the season of measurement.